CEL-SCI Corporation (CVM)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
0.23+0.01 (+2.36%)
At close: 4:02 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.22
Bid0.19 x 700
Ask4.12 x 1900
Day's Range0.22 - 0.24
52wk Range0.20 - 0.66
1y Target EstN/A
Market Cap35.01M
P/E Ratio (ttm)-1.25
Avg Vol (3m)720,235
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire5 days ago

    CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial

    CEL-SCI Corporation announced today: following up on our press release issued on September 26, 2016, we have received the Partial Clinical Hold letter from the U.S. Food and Drug Administration .

  • Capital Cube8 days ago

    ETF’s with exposure to CEL-SCI Corp. : October 18, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to CEL-SCI Corp. Here are 5 ETF’s with the largest exposure to CVM-US. Comparing the performance and risk of CEL-SCI Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Marketwired26 days ago

    CVR Medical Retains Brisco Capital Investor Relations

    CVR Medical Corp. is pleased to announce that it has entered into a consulting agreement effective as of September 27, 2016 with Brisco Capital Partners Corp. for the provision of investor relation services....